Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels
Mark A. Perazella(Yale University), Margaret J. Bia(Yale University), Alan S. Kliger(Yale University), Marc I. Lorber(United Therapeutics (United States)), Peter McPhedran(Yale University), Elliott Levy(Brigham and Women's Hospital)
Cited by 61
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery
|The American Journal of Medicine|1998|1.2k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
|Radiology|2020|582
Renal Vulnerability to Drug Toxicity
|Clinical Journal of the American Society of Nephrology|2009|402